Baker McKenzie Advises the Shareholders of Swiss Cardio Technologies AG on their Sale to Abacus Medicine Group
The shareholders of Swiss Cardio Technologies AG, a medical company that specializes in cardiovascular surgery solutions, received advice from Baker McKenzie about the sale of all of their shares to Abacus Medicine Group. Abacus Medicine Group is a prominent pharmaceutical company that was founded in Denmark in 2004 and is dedicated to improving access and affordability through the parallel importation of medications.